IMNN

0.53555.22%
FJ

Frederick J. Fritz

Independent Director

Mr. Frederick J. Fritz has been the Chief Executive Officer and President of Neuro Diagnostic Devices, Inc. since December 18, 2006. Mr. Fritz founded Valeo Medical in 2003 and developed the world's first non-invasive diagnostic test for endometriosis. Mr. Fritz served as Chief Executive Officer and President of Valeo Medical, Inc. Mr. Fritz has served as CEO and Founder of NeuroDx, a development stage diagnostic device company focused on the neurosurgery market, since 2006. In 1997, he founded Songbird Hearing, a medical device spin-off of the Sarnoff Corporation, which developed and launched the world's first disposable hearing aid. Mr. Fritz was President and CEO of Songbird Hearing, Inc., a medical device company spun out of Sarnoff Corporation. He began his career in marketing management and new product development. He joined Schering Plough's Wesley Jessen in 1985 as Vice President of marketing and sales and General Manager of Schering's over-the-counter pharmaceutical business since 1988 and of the podiatric products (Dr. Scholl, Lotrimin, Tinactin) business in 1990. Mr. Fritz served as the President of Coleman North America from 1995 to 1997. He has been a Director of Neuro Diagnostic Devices, Inc. since December 18, 2007. Mr. Fritz has been an Independent Director at Imunon, Inc. (formerly known as Celsion Corporation) since July 8, 2011. He served as a Director of Valeo Medical, Inc. Mr. Fritz holds a Master's in Business Administration from Harvard University and is a summa cum laude, Bachelor of engineering graduate from the University of Illinois.

公司職務